Telum Therapeutics is a synthetic biology company that develops new treatments for MDR infections caused by Gram negative bacteria based on the use of lytic enzymes from bacteriophages, called enzybiotics. The company has developed the APEX™️ Platform: Advanced Phage-derived Enzybiotics from eXploration that allows discovery of novel enzybiotics and engineering to create chimeric lytic enzymes.
- CEO & co-Founder: Roberto Díez
- CFO & co-Founder: Rubén Díez
- CSO: Chad Euler
- Location: Noáin (Navarra)
- Website: telumtherapeutics.com